Antimicrobial Resistance and Its Societal Implications: A Comprehensive Review

References (126)

1. 1 Mechanisms of Antibiotic Resistance [DOI]
2. 2 Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices [DOI]
3. 3 Antimicrobial Resistance: a One Health Perspective [DOI]
4. 4 Trends in Antimicrobial Drug Development: Implications for the Future [DOI]
5. 5 Agriculture and food animals as a source of antimicrobial-resistant bacteria [DOI]
6. 6 Pyrosequencing of Antibiotic-Contaminated River Sediments Reveals High Levels of Resistance and Gene Transfer Elements [DOI]
7. 7 Point-of-Care Testing for Infectious Diseases: Past, Present, and Future [DOI]
8. 8 Selective Pressure of Antibiotic Pollution on Bacteria of Importance to Public Health [DOI]
9. 9 Emergence and spread of antibiotic resistance following exposure to antibiotics [DOI]
10. 10 The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia [DOI]
11. 11 Use of antibiotics as feed additives: a burning question [DOI]
12. 12 A systematic review of the public's knowledge and beliefs about antibiotic resistance [DOI]
13. 13 Antimicrobial Resistance in Bacteria of Animal Origin [DOI]
14. 14 Antibiotics: Where did we go wrong? [DOI]
15. 15 Current and emerging techniques for antibiotic susceptibility tests [DOI]
16. 16 Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection [DOI]
17. 17 Toward a Predictive Understanding of Earth’s Microbiomes to Address 21st Century Challenges [DOI]
18. 18 Mobile elements, zoonotic pathogens and commensal bacteria: conduits for the delivery of resistance genes into humans, production animals and soil microbiota [DOI]
19. 19 Antibiotics/antibacterial drug use, their marketing and promotion during the post-antibiotic golden age and their role in emergence of bacterial resistance [DOI]
20. 20 The urgent need for new antibacterial agents [DOI]
21. 21 The patient's role in the spread and control of bacterial resistance to antibiotics [DOI]
22. 22 Today's Food System: How Healthy Is It? [DOI]
23. 23 The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes [DOI]
24. 24 Human health impacts of antibiotic use in agriculture: A push for improved causal inference [DOI]
25. 25 Narrowing the spectrum: the new frontier of precision antimicrobials [DOI]
26. 26 Multidisciplinary and multisectoral coalitions as catalysts for action against antimicrobial resistance: Implementation experiences at national and regional levels [DOI]
27. 27 Rapid Antimicrobial Susceptibility Testing with Electrokinetics Enhanced Biosensors for Diagnosis of Acute Bacterial Infections [DOI]
28. 28 Optimal Resting-Growth Strategies of Microbial Populations in Fluctuating Environments [DOI]
29. 29 There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy [DOI]
30. 30 The evolution of resistance against good and bad infections [DOI]
31. 31 Novel Strategies to Combat Antimicrobial Resistance [DOI]
32. 32 The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care [DOI]
33. 33 Challenges in the Design of Multitarget Drugs Against Multifactorial Pathologies: A New Life for Medicinal Chemistry? [DOI]
34. 34 Guided evolution of in silico microbial populations in complex environments accelerates evolutionary rates through a step-wise adaptation [DOI]
35. 35 Antimicrobial Properties of Various Non-Antibiotic Drugs against Microorganisms [DOI]
36. 36 Mutations as a Basis of Antimicrobial Resistance [DOI]
37. 37 Broth dilution minimum inhibitory concentrations: rationale for use of selected antimicrobial concentrations [DOI]
38. 38 Horizontal Gene Transfer [DOI]
39. 39 'Evolution-Proofing' Antibacterials [DOI]
40. 40 A Review on Antibiotic Resistant and Implication on Food Chain
41. 41 Antimicrobial resistance - why do we have it and what can we do about it? [DOI]
42. 42 Level of patient information on antibiotic use [DOI]
43. 43 Emergence & spread of Multiresistant Organisms: Can Infection Control measures help? [DOI]
44. 44 Current and Novel Methods in Clinical Microbiology: Advantages and Pitfalls when Facing the Menace of Antimicrobial Resistance [DOI]
45. 45 Clinical Microbiology and Infection [DOI]
46. 46 How to Prescribe Fewer Unnecessary Antibiotics: Talking Points That Work with Patients and Their Families.
47. 47 Commentary on “The Impact of Anti-Infective Drug Shortages on Hospitals in the United States: Trends and Causes” [DOI]
48. 48 Introduction: DRIVE-AB’s definitions and indicators to monitor responsible antibiotic use [DOI]
49. 49 Rapid Detection of Pathogens [DOI]
50. 50 Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections [DOI]
51. 51 Metal-Based Nanoparticles as Antimicrobial Agents: An Overview [DOI]
52. 52 Comparative Analyses of Vertebrate Gut Microbiomes Reveal Convergence between Birds and Bats [DOI]
53. 53 Global geographic trends in antimicrobial resistance: the role of international travel [DOI]
54. 54 Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries [DOI]
55. 55 Antimicrobial use in food animals and human health: time to implement ‘One Health’ approach [DOI]
56. 56 Selection and dissemination of antimicrobial resistance in Agri-food production [DOI]
57. 57 Travel-Related Antimicrobial Resistance: A Systematic Review [DOI]
58. 58 Antibiotic Use in Low and Middle-Income Countries and the Challenges of Antimicrobial Resistance in Surgery [DOI]
59. 59 Environmental Spread of Antibiotic Resistance [DOI]
60. 60 Antimicrobial resistance – moving forward? [DOI]
61. 61 Resetting the agenda for antibiotic resistance through a health systems perspective [DOI]
62. 62 Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance [DOI]
63. 63 Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria [DOI]
64. 64 Not a magic pill: a qualitative exploration of provider perspectives on antibiotic prescribing in the outpatient setting [DOI]
65. 65 Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries [DOI]
66. 66 The Slow-Motion Catastrophe of Antimicrobial Resistance and Practical Interventions for All Prescribers [DOI]
67. 67 Public awareness and individual responsibility needed for judicious use of antibiotics: a qualitative study of public beliefs and perceptions [DOI]
68. 68 The Super-Wicked Problem of Antimicrobial Resistance [DOI]
69. 69 Governing antimicrobial resistance: a narrative review of global governance mechanisms [DOI]
70. 70 Comprehensive screening of genomic and metagenomic data reveals a large diversity of tetracycline resistance genes [DOI]
71. 71 To Push or To Pull? In a Post-COVID World, Supporting and Incentivizing Antimicrobial Drug Development Must Become a Governmental Priority [DOI]
72. 72 Antimicrobial-resistant bacteria in international travelers [DOI]
73. 73 National action to combat AMR: a One-Health approach to assess policy priorities in action plans [DOI]
74. 74 Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers [DOI]
75. 75 Modeling Multispecies Gene Flow Dynamics Reveals the Unique Roles of Different Horizontal Gene Transfer Mechanisms [DOI]
76. 76 Country Income Is Only One of the Tiles: The Global Journey of Antimicrobial Resistance among Humans, Animals, and Environment [DOI]
77. 77 Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa [DOI]
78. 78 Diagnostic Tests Can Stem the Threat of Antimicrobial Resistance: Infectious Disease Professionals Can Help [DOI]
79. 79 Shorter and Longer Courses of Antibiotics for Common Infections and the Association With Reductions of Infection-Related Complications Including Hospital Admissions [DOI]
80. 80 Diagnostic tools for tackling febrile illness and enhancing patient management [DOI]
81. 81 Will the Overuse of Antibiotics During the Coronavirus Pandemic Accelerate Antimicrobial Resistance of Bacteria? [DOI]
82. 82 An overview on impact and application of microorganisms on human health, medicine and environment [DOI]
83. 83 Updates on Infection Control in Alternative Health Care Settings [DOI]
84. 84 Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings [DOI]
85. 85 Ecology of Pathogens and Antibiotic-resistant Bacteria in Environments: Challenges and Opportunities [DOI]
86. 86 Antimicrobial use data collection in animal agriculture [DOI]
87. 87 Beta-lactams susceptibility testing of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis isolates: a comparative assessment of Etest and disk diffusion methods against broth dilution [DOI]
88. 88 A roadmap for the generation of benchmarking resources for antimicrobial resistance detection using next generation sequencing [DOI]
89. 89 Inclusion of next-generation leaders and cost-effective precision diagnostic techniques are vital in combatting antimicrobial resistance in low- and middle-income countries [DOI]
90. 90 Antimicrobial Resistance, the COVID-19 Pandemic, and Lessons for the Orthopaedic Community [DOI]
91. 91 Feasibility and potential significance of rapid in vitro qualitative phenotypic antimicrobial susceptibility testing of gram-negative bacilli with the ProMax system [DOI]
92. 92 Innovative strategies to fight antimicrobial resistance: crowdsourcing to expand medical training [DOI]
93. 93 Role of Horizontal Gene Transfer in Bacteria
94. 94 Antimicrobial Resistance Strategies: Are We Approaching the End? [DOI]
95. 95 Metagenomic Next-generation Sequencing: Application in Infectious Diseases [DOI]
96. 96 An Agricultural Perspective for Combating Antibiotic Resistance: A Literature Review [DOI]
97. 97 Impact of Antimicrobial Use in Animals and Regulatory Response [DOI]
98. 98 Integrating Metagenomics in the Routine Lab [DOI]
99. 99 A Bayesian Latent Class Mixture Model With Censoring for Correlation Analysis in Antimicrobial Resistance Across Populations [DOI]
100. 100 THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [DOI]
101. 101 Bacterial Antibiotic Resistance: The Most Critical Pathogens [DOI]
102. 102 Towards the sustainable discovery and development of new antibiotics [DOI]
103. 103 Mechanisms of antimicrobial resistance in bacteria [DOI]
104. 104 Antimicrobial resistance: One Health approach [DOI]
105. 105 Antimicrobial resistance: a top ten global public health threat [DOI]
106. 106 Antimicrobial Resistance in the Food Chain: Trends, Mechanisms, Pathways, and Possible Regulation Strategies [DOI]
107. 107 Antimicrobial Resistance: a One Health Perspective [DOI]
108. 108 Surveillance and prevalence of antimicrobial resistant bacteria from public settings within urban built environments: Challenges and opportunities for hygiene and infection control [DOI]
109. 109 Gene sharing among plasmids and chromosomes reveals barriers for antibiotic resistance gene transfer [DOI]
110. 110 Multiform antimicrobial resistance from a metabolic mutation [DOI]
111. 111 The Case against Antibiotics and for Anti-Virulence Therapeutics [DOI]
112. 112 Antimicrobial agents and microbial ecology [DOI]
113. 113 Amplification-free detection of bacterial genes using a signaling probe-based DNA microarray [DOI]
114. 114 Point of care testing for infectious disease: ownership and quality [DOI]
115. 115 Prediction of Minimal Inhibitory Concentration of Meropenem Against Klebsiella pneumoniae Using Metagenomic Data [DOI]
116. 116 A rapid evidence assessment exploring whether antimicrobial resistance complicates non-infectious health conditions and healthcare services, 2010–20 [DOI]
117. 117 Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics [DOI]
118. 118 Application and Integration of Omics-powered Diagnostics in Clinical and Public Health Microbiology [DOI]
119. 119 The Effect of Mid-to-Long-Term Hospitalization on the Catastrophic Health Expenditure: Focusing on the Mediating Effect of Earned Income Loss [DOI]
120. 120 Antimicrobial Resistance and Its Societal Implications: A Comprehensive Review [DOI]
121. 121 Tackling Anti-microbial Resistance: An Ethical Framework for Rational Antibiotic Use [DOI]
122. 122 A Review on Antimicrobial Stewardship Programs in Multiple Care Settings [DOI]
123. 123 The Need for a One Health Approach to Zoonotic Diseases and Antimicrobial Resistance [DOI]
124. 124 Philosophical Transactions of the Royal Society B: biological sciences [DOI]
125. 125 Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal [DOI]
126. 126 Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics [DOI]

Cited by 8

Showing 3 of 8 known citations — external sources report more than can currently be individually listed.

Related research

• Expectations and Realities: The Views and Experiences of HIV/AIDS Patients on Ghana’s National Health Insurance Scheme — shares topic coverage
• Availability and Readiness of Antenatal Care in the Primary Healthcare Setting in Ogoniland — shares topic coverage
• Satisfaction with Quality of Health Care among Teaching Hospitals in Kathmandu, Nepal — shares topic coverage
• Medical Tourism, Public Health and Economic Development in Nigeria: Issues and Prospects — shares topic coverage
• A Preliminary Review of Diversity in the Healthcare Workplace — shares topic coverage